Folgen
Antonio Gasbarrini
Antonio Gasbarrini
Professor of Gastroenterology, Catholic University, Gemelli Hospital, Rome, Italy
Bestätigte E-Mail-Adresse bei iol.it
Titel
Zitiert von
Zitiert von
Jahr
Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report
P Malfertheiner, F Megraud, CA O'morain, JP Gisbert, EJ Kuipers, ...
Gut 66 (1), 6-30, 2017
3745*2017
What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases
E Rinninella, P Raoul, M Cintoni, F Franceschi, GAD Miggiano, ...
Microorganisms 7 (1), 14, 2019
24802019
Statements from the Taormina expert meeting on occult hepatitis B virus infection
G Raimondo, JP Allain, MR Brunetto, MA Buendia, DS Chen, M Colombo, ...
Journal of hepatology 49 (4), 652-657, 2008
11172008
European consensus conference on faecal microbiota transplantation in clinical practice
G Cammarota, G Ianiro, H Tilg, M Rajilić-Stojanović, P Kump, R Satokari, ...
Gut 66 (4), 569-580, 2017
10562017
Proteobacteria: a common factor in human diseases
G Rizzatti, LR Lopetuso, G Gibiino, C Binda, A Gasbarrini
BioMed research international 2017, 2017
8302017
Commensal Clostridia: leading players in the maintenance of gut homeostasis
LR Lopetuso, F Scaldaferri, V Petito, A Gasbarrini
Gut pathogens 5, 1-8, 2013
8202013
Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori
A Gasbarrini, F Franceschi, R Tartaglione, R Landolfi, P Pola, ...
The Lancet 352 (9131), 878, 1998
7761998
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection
G Cammarota, L Masucci, G Ianiro, S Bibbo, G Dinoi, G Costamagna, ...
Alimentary pharmacology & therapeutics 41 (9), 835-843, 2015
6582015
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
A Santoro, L Rimassa, I Borbath, B Daniele, S Salvagni, JL Van Laethem, ...
The lancet oncology 14 (1), 55-63, 2013
6532013
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis
MA Zocco, LZ Dal Verme, F Cremonini, AC Piscaglia, EC Nista, ...
Alimentary pharmacology & therapeutics 23 (11), 1567-1574, 2006
6432006
Meta‐analysis: the effect of probiotic administration on antibiotic‐associated diarrhoea
F Cremonini, S Di Caro, EC Nista, F Bartolozzi, G Capelli, G Gasbarrini, ...
Alimentary pharmacology & therapeutics 16 (8), 1461-1467, 2002
6232002
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute‐on‐chronic liver failure: the RELIEF trial
R Bañares, F Nevens, FS Larsen, R Jalan, A Albillos, M Dollinger, ...
Hepatology 57 (3), 1153-1162, 2013
6192013
Extraintestinal manifestations in inflammatory bowel disease
S Danese, S Semeraro, A Papa, I Roberto, F Scaldaferri, G Fedeli, ...
World journal of gastroenterology 11 (46), 7227, 2005
5852005
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development
MA Zocco, E Di Stasio, R De Cristofaro, M Novi, ME Ainora, F Ponziani, ...
Journal of hepatology 51 (4), 682-689, 2009
5702009
Antibiotics as deep modulators of gut microbiota: between good and evil
G Ianiro, H Tilg, A Gasbarrini
Gut 65 (11), 1906-1915, 2016
5692016
Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review
G Cammarota, G Ianiro, A Gasbarrini
Journal of clinical gastroenterology 48 (8), 693-702, 2014
5652014
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference.
A Gasbarrini, GR Corazza, G Gasbarrini, M Montalto, M Di Stefano, ...
Alimentary pharmacology & therapeutics 29, 1-49, 2009
5622009
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL# 3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo …
A Tursi, G Brandimarte, A Papa, A Giglio, W Elisei, GM Giorgetti, G Forti, ...
The American journal of gastroenterology 105 (10), 2218, 2010
5522010
Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study
F Cremonini, S Di Caro, M Covino, A Armuzzi, M Gabrielli, L Santarelli, ...
The American journal of gastroenterology 97 (11), 2744-2749, 2002
5362002
Food components and dietary habits: keys for a healthy gut microbiota composition
E Rinninella, M Cintoni, P Raoul, LR Lopetuso, F Scaldaferri, G Pulcini, ...
Nutrients 11 (10), 2393, 2019
5302019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20